stockrow
Saturday 7 November 2026
Export LYCA’s income statement to Excel — free account
Lycia Therapeutics Inc.
LYCA Healthcare Biotechnology
30.50
1.70
+5.90%
Follow LYCA
Alert me
Lycia Therapeutics Inc. (LYCA) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ZBIO Zenas BioPharma, Inc. compare | n/m |
| STOK Stoke Therapeutics, Inc. compare | n/m |
| ABSI Absci Corporation compare | n/m |
| SLS SELLAS Life Sciences Group, Inc. compare | n/m |
| GENB Generate Biomedicines, Inc. compare | n/m |
| AGIO Agios Pharmaceuticals, Inc. compare | n/m |
| NVAX Novavax, Inc. compare | n/m |
| NRIX Nurix Therapeutics, Inc. compare | 6.1× |
| LYCA Lycia Therapeutics Inc. | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)